In conclusion, our study demonstrates a role for USP14 in endothelial cells and BBB dysfunction as well as subsequent neuroinflammation after ischemic stroke, suggesting that targeting endothelial cell tight junction protein degradation through USP14 inhibition is an attractive therapeutic strategy for attenuating neuroinflammation and brain injury after ischemic stroke. Here, USP14 is linked to ischemic stroke.